Get started
Author

Estelle Thébaud

Observed names: E Thebaud, E. Thebaud, E. Thebaud-Leculee, E. Thébaud, Estelle Leculée‐Thébaud, Estelle Thebaud, Estelle Thebaud-Leculee, Estelle Thebaud-Leculée, Estelle Thébaud-Léculée, LECULEE-THEBAUD, Estelle, Thebaud E, Thebaud, Estelle
Observed institutions: University of Padua, Inserm, Hotel Dieu Hospital, Institut Gustave Roussy, Centre Hospitalier Universitaire de Lille, Centre Hospitalier Universitaire de Nantes, Lille’s Cardiology Hospital, Sorbonne Paris Cité, Hôpital Jeanne de Flandre, Centre Oscar Lambret, Hôpital Mère-Enfant, Azienda Ospedale - Università Padova, Fondazione IRCCS Istituto Nazionale dei Tumori, Hôpital de la Timone, Université Paris Descartes, Institut Curie, Nantes Université
ORCID: 0000-0003-0516-4103
Observed ORCID: 0000-0003-0516-4103
OpenAlex ID: A5038316850
Infantile Fibrosarcoma: Management Based on the European Experience
2009 · Daniel Orbach, Annie Rey, et al. · Journal of Clinical Oncology · 241
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
2022 · Pablo Berlanga, Gaelle Pierron, et al. · Cancer Discovery · 174
PDF
Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity
2015 · Adeline Granzotto, Mohamed Amine Benadjaoud, et al. · International Journal of Radiation Oncology*Biology*Physics · 123
Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
2016 · Mathieu Chicard, Sandrine Boyault, et al. · Clinical Cancer Research · 113
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study
2021 · Nathalie Gaspar, Rajkumar Venkatramani, et al. · The Lancet Oncology · 89
Results of a Multicenter Prospective Study on the Postoperative Treatment of Unilateral Retinoblastoma After Primary Enucleation
2013 · Isabelle Aerts, Xavier Sastre-Garau, et al. · Journal of Clinical Oncology · 80
Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis
2015 · Angela Bellini, Virginie Bernard, et al. · Clinical Cancer Research · 75
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors
2016 · Thomas Pincez, Nathalie Clément, et al. · Pediatric Blood & Cancer · 66
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆
2021 · N. Gaspar, Q. Campbell-Hewson, et al. · ESMO Open · 59
PDF
Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium
2021 · Claudia Pasqualini, Jonathan Rubino, et al. · European Journal of Cancer · 56
PDF
Predicting the risk of severe bacterial infection in children with chemotherapy‐induced febrile neutropenia
2010 · Emilie Macher, François Dubos, et al. · Pediatric Blood & Cancer · 56
PDF
Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends
2012 · Marie‐Laure Couec, Nicolas André, et al. · Pediatric Blood & Cancer · 52
Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE)
2020 · Marie de Tersant, Lucile Généré, et al. · Journal of the Endocrine Society · 45
Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?
2014 · M. Ben Arush, V. Minard-Colin, et al. · European Journal of Cancer · 43
Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution
2015 · E Brissot, F Rialland, et al. · Bone Marrow Transplantation · 38
Risk of neuroblastoma, birth‐related characteristics, congenital malformations and perinatal exposures: A pooled analysis of the ESCALE and ESTELLE French studies (SFCE)
2016 · Paula Rios, Helen D Bailey, et al. · International Journal of Cancer · 36
PDF
Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial
2021 · Francisco Bautista, Xavier Paoletti, et al. · Journal of Clinical Oncology · 35
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
2024 · Patricia Raiser, Gudrun Schleiermacher, et al. · European Journal of Cancer · 34
PDF
Single-agent expansion cohort of lenvatinib (LEN) and combination dose-finding cohort of LEN + etoposide (ETP) + ifosfamide (IFM) in patients (pts) aged 2 to ≤25 years with relapsed/refractory osteosarcoma (OS).
2018 · Nathalie Gaspar, Michela Casanova, et al. · Journal of Clinical Oncology · 31
Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma
2019 · Angela Bellini, Nadia Bessoltane‐Bentahar, et al. · International Journal of Cancer · 30
PDF
Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma
2017 · Clement Bailly, Rodolphe Leforestier, et al. · PLoS ONE · 30
PDF
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
2024 · Lucas Moreno, Rebekah Weston, et al. · Journal of Clinical Oncology · 27
Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease
2021 · Joanna Cyrta, Arnaud Gauthier, et al. · The American Journal of Surgical Pathology · 26
Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tissue sarcoma Study Group recommendations
2021 · Maxime Enault, Véronique Minard-Colin, et al. · European Journal of Cancer · 25
PDF
Salvage therapy for refractory or recurrent pediatric germ cell tumors: The french SFCE experience
2013 · Cecile Faure-Conter, Daniel Orbach, et al. · Pediatric Blood & Cancer · 24
Works count: 181
Citation count: 2,076
H-index: 24
I10-index: 45
Year
Topic
Type